Open in QuartrAvailable for iOS and Android

Bavarian Nordic
Bavarian Nordic is a clinical-stage biopharmaceutical company that develops and commercializes life-saving vaccines in the areas of cancer and infectious diseases. Its fast-growing portfolio today includes Aeras, an influenza vaccine that has been approved in the United States, Europe, and Canada, and the company is advancing a pipeline of novel, next generation vaccines designed to complement its portfolio. Bavarian Nordic A/S was incorporated in 1992 and is headquartered in Hellerup, Denmark.
Latest events on Quartr
Previous Events for Bavarian Nordic
Ticker
BAVA
Country
Denmark
About the company
https://www.bavarian-nordic.com/about.aspx